• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Smart Meter announces free program to reduce diabetes care costs

March 31, 2023 By Sean Whooley

Smart Meter logoSmart Meter today announced its iGlucose Challenge to healthcare payors and providers in the U.S. to improve care costs for people with diabetes.

Tampa, Florida-based Smart Meter aims to reduce the cost of care and lower A1C for people managing diabetes. The company, which provides remote patient monitoring solutions, offers this as a no-risk, performance-based program. The company said it issued the challenge to companies who pay and care for persons with diabetes.

It features no upfront costs for the first three payors and providers that agree to participate. Enrolled patients or members owe no fees, Smart Meter said. The challenge merges blood glucose monitoring with active coaching and education to help patients manage their care. If patients lower A1C after a four-month period, the payor of a participating healthcare provider organization for each successful patient or member pays the performance fee.

Smart Meter said its goal with this challenge is to reduce the total cost of care for payors and providers. The company wants to reduce A1C levels and help people with diabetes better manage their disease.

“One of our primary responsibilities as the leading supplier of healthcare data and technology to the RPM industry is developing innovative approaches that help our nationwide network of customers expand care to a broader set of patients,” said Casey Pittock, CEO of Smart Meter. “The iGlucose Challenge is a new care model we developed to encourage payors and providers to expand services to patients who are not properly managing their diabetes or have been unable to do so due to economic factors.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: smartmeter

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS